未登录

W

Wenhuan Xiao

Yangzhou University

H指数:10

被引数:307

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Brain-derived neurotrophic factor, sex hormones and cognitive decline in male patients with schizophrenia receiving continuous antipsychotic therapy

world psychiatry

IF3.4

2023-12-191

OAAI

16S rRNA gene sequencing reveals the effect of fluoxetine on gut microbiota in chronic unpredictable stress-induced depressive-like rats

general psychiatry

IF3.1

2023-08-033

OAAI

Antipsychotic drugs increase Neuregulin1β1 serum levels in first-episode drug-naive patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptoms

IF3.6

2022-03-256

OAAI

Decreased neuregulin181 in first episode and drug-naive patients with schizophrenia: Negative correlation with cognitive impairment

PSYCHIATRY RESEARCH

IF3.9

2021-10-013

PREAI

Altered levels of BMD, PRL, BAP and TRACP-5b in male chronic patients with schizophrenia

SCIENTIFIC REPORTS

IF3.9

2020-08-125

OAAI

Decreased Serum EGF in First-episode and Chronic Schizophrenia Patients: Negative Correlation with Psychopathology

SCIENTIFIC REPORTS

IF3.9

2020-04-164

OAAI

Neurotrophic factor changes are essential for predict electroconvulsive therapy outcome in schizophrenia

SCHIZOPHRENIA RESEARCH

IF3.5

2020-04-016

PREAI

Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia

EUROPEAN PSYCHIATRY

IF6.7

2020-03-2340

PREAI

Serum Epidermal Growth Factor is Low in Schizophrenia and Not Affected by Antipsychotics Alone or Combined With Electroconvulsive Therapy

FRONTIERS IN PSYCHIATRY

IF3.2

2020-03-035

OAAI

Neurocognition and social cognition in remitted first-episode schizophrenia: correlation with VEGF serum levels

IF3.6

2019-12-1611

OAAI

Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction

IF3.6

2019-08-1627

OAAI

Altered serum levels of vascular endothelial growth factor in first-episode drug-naive and chronic medicated schizophrenia

首发药物治疗和慢性药物治疗的精神分裂症患者血清血管内皮生长因子水平的改变

PSYCHIATRY RESEARCH

IF3.9

2018-06-0112

PREAI

Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2018-05-0113

PREAI

Elevated serum vascular endothelial growth factor in treatment-resistant schizophrenia treated with electroconvulsive therapy: Positive association with therapeutic effects

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

IF3.8

2018-04-2613

PREAI

Cognitive impairment in first-episode drug-naive patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2017-06-0142

PREAI

Atypical antipsychotic treatment increases glial cell line-derived neurotrophic factor serum levels in drug-free schizophrenic patients along with improvement of psychotic symptoms and therapeutic effects

PSYCHIATRY RESEARCH

IF3.9

2016-12-0115

PREAI